OptimizeRx Corp — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2021-01-04

Reporting Person: BAKER DOUGLAS P (CHIEF FINANCIAL OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-04	Common Stock	S	8334	$32.88	Disposed	82371	Direct
2021-01-04	Common Stock	M	4566	$2.46	Acquired	86937	Direct
2021-01-04	Common Stock	M	4000	$7.51	Acquired	90937	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-04	Stock Option	$2.46	M	4566	Disposed	2022-03-31	Common Stock (4566)	Direct
2021-01-04	Stock Option	$7.51	M	4000	Disposed	2025-03-11	Common Stock (4000)	Direct

Footnotes

F1: These shares sold pursuant to a plan of disposition adopted on September 22, 2020 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended